Advanced Search

 

Study ID Status Title Patient Level Data
113489_2 Completed An assessment of the Independent effect of oral antidiabetic agents and insulin exposure on the risk of myocardial infarction in type 2 diabetic patients
113492 Completed Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
113492_1 Completed Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
113492_2 Completed Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
113497 Completed Reports of neoplasms in rosiglitazone clinical trials
113497_1 Completed Reports of neoplasms in rosiglitazone clinical trials
113497_2 Completed Reports of neoplasms in rosiglitazone clinical trials
113502 Completed Prophylactic efficacy of Relenza against influenza A and B
113505 Completed Coronary heart disease outcomes in patients receiving antidiabetic therapy
113505_1 Completed Thiazolidinediones and coronary heart disease in a US health insurance database
113506 Completed A study to investigate the interaction of GSK1292263 with rosuvastatin and simvastatin in healthy subjects Study Listed on ClinicalStudyDataRequest.com
113517 Completed A Phase I Open-Label Dose Escalation Study of the Focal Adhesion Kinase Inhibitor, GSK2256098, in Subjects with Solid Tumors Study Listed on ClinicalStudyDataRequest.com
113518 Completed Reactogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated liquid human rotavirus (HRV) vaccine 444563, in healthy infants Study Listed on ClinicalStudyDataRequest.com
113519 Completed Immunogenicity and safety study of GSK Biologicals’ influenza candidate vaccine GSK2340274A Study Listed on ClinicalStudyDataRequest.com
113522 Completed Post-marketing safety study of autoimmune diseases following Cervarix® vaccination in females aged 9-25 years in the US
113525 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ influenza GSK2340272A and Fluarix™ 2009-2010 vaccines when co-administered in elderly subjects aged 61 years and older Study Listed on ClinicalStudyDataRequest.com
113528 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 17 years Study Listed on ClinicalStudyDataRequest.com
113535 Completed Immunological equivalence between GSK2340272A and GSK2340274A influenza vaccines in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113536 Completed A study to evaluate the safety and immunogenicity of an A/California/7/2009 (H1N1)v-like vaccine GSK2340274A or GSK2340273A co-administered with trivalent inactivated seasonal influenza vaccine in adults 19 to 40 years of age Study Listed on ClinicalStudyDataRequest.com
113545 Completed Reactogenicity and safety of a single dose of GlaxoSmithKline (GSK) Biologicals’ human rotavirus (HRV) vaccine (444563) in healthy adults Study Listed on ClinicalStudyDataRequest.com
113552 Completed Reactogenicity and safety of a single dose of GlaxoSmithKline (GSK) Biologicals’ human rotavirus (HRV) vaccine (444563) in healthy children Study Listed on ClinicalStudyDataRequest.com
113554 Completed An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of Nebilet administered in Korean patients according to the prescribing information
113555 Completed A two-part study to evaluate the safety, tolerability and pharmacokinetics of single and repeat oral doses of pazopanib in healthy adult subjects
113564 Completed Sero-prevalence of Hepatitis A, Varicella-Zoster virus, Cytomegalovirus, Herpes Simplex and Bordetella pertussis in Mexico
113572 Completed Immunogenicity and safety of GSK Biologicals’ pandemic influenza candidate vaccine GSK2340272A Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.